A detailed history of Saxon Interests, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Saxon Interests, Inc. holds 444 shares of LLY stock, worth $347,727. This represents 0.18% of its overall portfolio holdings.

Number of Shares
444
Previous 339 30.97%
Holding current value
$347,727
Previous $306,000 28.43%
% of portfolio
0.18%
Previous 0.15%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$772.14 - $960.02 $81,074 - $100,802
105 Added 30.97%
444 $393,000
Q2 2024

Jul 18, 2024

BUY
$724.87 - $909.04 $2,899 - $3,636
4 Added 1.19%
339 $306,000
Q1 2024

Apr 18, 2024

BUY
$592.2 - $792.28 $198,387 - $265,413
335 New
335 $260,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $744B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Saxon Interests, Inc. Portfolio

Follow Saxon Interests, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saxon Interests, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Saxon Interests, Inc. with notifications on news.